Page 43 - GTM-2-2

Global Translational Medicine Gut microbiota in Onco-Hematology

https://doi.org/10.1126/science.aad1329 (Warsz), 64: 255–258.
63. Sivan A, Corrales L, Hubert N, et al., 2015, Commensal https://doi.org/10.1007/s00005-016-0387-9
Bifidobacterium promotes antitumor immunity and 73. De Castro CG Jr., Ganc AJ, Ganc RL, et al., 2015, Fecal
facilitates anti-PD-L1 efficacy. Science, 350: 1084–1089. microbiota transplant after hematopoietic SCT: Report of a
https://doi.org/10.1126/science.aac4255 successful case. Bone Marrow Transplant, 50: 145.
64. Pitt JM, Vetizou M, Boneca IG, et al., 2017, Enhancing https://doi.org/10.1038/bmt.2014.212
the clinical coverage and anticancer efficacy of immune 74. Kaito S, Toya T, Yoshifuji K, et al., 2018, Fecal microbiota
checkpoint blockade through manipulation of the gut transplantation with frozen capsules for a patient with
microbiota. Oncoimmunology, 6: e1132137. refractory acute gut graft-versus-host disease. Blood Adv,
https://doi.org/10.1080/2162402X.2015.1132137 2: 3097–3101.
65. Routy B, Le Chatelier E, Derosa L, et al., 2018, Gut microbiome https://doi.org/10.1182/bloodadvances.2018024968
influences efficacy of PD-1-based immunotherapy against 75. Rajagopala SV, Yooseph S, Harkins DM, et al., 2016,
epithelial tumors. Science, 359: 91–97. Gastrointestinal microbial populations can distinguish
https://doi.org/10.1126/science.aan3706 pediatric and adolescent Acute Lymphoblastic Leukemia
(ALL) at the time of disease diagnosis. BMC Genomics,
66. Gopalakrishnan V, Spencer CN, Nezi L, et al., 2018, 17: 635.
Gut microbiome modulates response to anti-PD-1
immunotherapy in melanoma patients. Science, 359: 97–103. https://doi.org/10.1186/s12864-016-2965-y
https://doi.org/10.1126/science.aan4236 76. Han L, Zhang H, Chen S, et al., 2019, Intestinal microbiota
can predict acute graft-versus-host disease following
67. Du C, Luo Y, Walsh S, et al., 2021, Oral fecal microbiota allogeneic hematopoietic stem cell transplantation. Biol
transplant capsules are safe and effective for recurrent Blood Marrow Transplant, 25: 1944–1955.
Clostridioides difficile infection: A systematic review and
meta-analysis. J Clin Gastroenterol, 55: 300–308. https://doi.org/10.1016/j.bbmt.2019.07.006
https://doi.org/10.1097/MCG.0000000000001495 77. Galloway-Peña JR, Smith DP, Sahasrabhojane P, et al., 2016,
The role of the gastrointestinal microbiome in infectious
68. Umesaki Y, Setoyama H, Matsumoto S, et al., 1993, complications during induction chemotherapy for acute
Expansion of alpha beta T-cell receptor-bearing intestinal myeloid leukemia. Cancer, 122: 2186–2196.
intraepithelial lymphocytes after microbial colonization
in germ-free mice and its independence from thymus. https://doi.org/10.1002/cncr.30039
Immunology, 79: 32–37. 78. Pepeljugoski CA, Morgan G, Braunstein M, 2019, Analysis
https://doi.org/10.1002/eji.1830260434 of intestinal microbiome in multiple myeloma reveals
progressive dysbiosis compared with MGUS and healthy
69. McDonald LC, Gerding DN, Johnson S, et al., 2018, Clinical individuals. Blood, 134: 3076.
practice guidelines for Clostridium difficile infection in adults
and children: 2017 update by the infectious diseases society https://doi.org/10.1182/blood-2019-130643
of America (IDSA) and society for healthcare epidemiology 79. Pianko MJ, Devlin SM, Littmann ER, et al., 2019, Minimal
of America (SHEA). Clin Infect Dis, 66: e1–e48. residual disease negativity in multiple myeloma is associated
https://doi.org/10.1093/cid/cix1085 with intestinal microbiota composition. Blood Adv,
3: 2040–2044.
70. Kim S, Covington A, Pamer EG, 2017, The intestinal
microbiota: Antibiotics, colonization resistance, and enteric https://doi.org/10.1182/bloodadvances.2019032276
pathogens. Immunol Rev, 279: 90–105. 80. Peled JU, Devlin SM, Staffas A, et al., 2017, Intestinal
http://dx.doi.org/10.1111/imr.12563 microbiota and relapse after hematopoietic-cell
transplantation. J Clin Oncol, 35: 1650–1659.
71. Innes AJ, Mullish BH, Fernando F, et al., 2017, Faecal
microbiota transplant: A novel biological approach to https://doi.org/10.1200/JCO.2016.70.3348
extensively drug-resistant organism-related non-relapse 81. Reichardt N, Duncan SH, Young P, et al., 2014, Phylogenetic
mortality. Bone Marrow Transplant, 52: 1452–1454. distribution of three pathways for propionate production
within the human gut microbiota. ISME J, 8: 1323–1335.
https://doi.org/10.1038/bmt.2017.151
72. Biliński J, Grzesiowski P, Muszyński J, et al., 2016, Fecal https://doi.org/10.1038/ismej.2014.14
microbiota transplantation inhibits multidrug-resistant 82. Smith PM, 2013, The microbial metabolites, short-chain
gut pathogens: Preliminary report performed in an fatty acids, regulate colonic Treg cell homeostasis. Science,
immunocompromised host. Arch Immunol Ther Exp 341: 569–573.

Volume 2 Issue 2 (2023) 13 https://doi.org/10.36922/gtm.0389